Avricore Health Inc. released its mid-year corporate update, revealing promising results for the health and wellness company. The update showed the company is on the right track and is well-positioned to meet its strategic goals for the remainder of the year.
Since its inception in 2016, Avricore Health Inc. is leading the charge in the digital healthcare sphere. Through partnerships with healthcare providers and offering an array of digital health solutions, Avricore is committed to the goal of delivering better outcomes for Canadians when it comes to managing their health.
The company’s mid-year corporate update included several key highlights, including:
– The launch of Avricore Bloodworks, the first-ever direct-to-consumer digital lab test platform. Avricore Bloodworks provides Canadians with access to medical blood tests from the comfort of their own home.
– Expansion of their network of healthcare providers to over 1,500 providers across Canada.
– A successful shift to virtual care resulted in a 60% month–over–month increase in telemedicine visits.
– Going public on the Toronto Stock Exchange, representing an important milestone in Avricore’s growth and providing increased financial flexibility to continue executing its growth strategy.
– Announced several new partnerships, including a major drugstore chain and a national fitness chain, both of which will offer their customers access to Avricore’s platform.
These highlights demonstrate the remarkable progress that Avricore Health has made in a short amount of time. The company’s mid-year update indicates that its strategic initiatives are on track and that the company is well-positioned to meet its goals for the remainder of the year.
As the healthcare industry accelerates its transition to digital and more Canadians look for innovative ways to manage their health, Avricore Health is in an advantageous position to capitalize on this trend. The company’s mid-year corporate update is a testament to its success so far and a reassuring sign of the growth potential to come.
